# hCT-MSC Infusion in Adults With Autism Spectrum Disorder

> **NCT04484077** · PHASE1 · COMPLETED · sponsor: **Joanne Kurtzberg, MD** · enrollment: 8 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Autism

## Interventions

- **BIOLOGICAL:** hCT-MSC

## Key facts

- **NCT ID:** NCT04484077
- **Lead sponsor:** Joanne Kurtzberg, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484077, "hCT-MSC Infusion in Adults With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04484077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*